Did you know that the final savings for the 3rd World ADC Asia are expiring this Friday, June 24?
Book Your Place Here --> www.worldadc-asia.com
Coming back to the APAC region this year, this is your mid-year industry touchpoint to help you overcome all your region-specific ADC-related issues and continue being part of the pioneers trailblazing these therapies to approval and beyond.
There has never been a stronger time to meet the antibody-drug conjugate community in Asia, with the Japanese-born Enhertu reaching blockbuster status; Asia accounting for half of the new ADC clinical trials in2023 and surpassing the number of those from the US for 5 years in a row.
Can you afford to miss this?
Remember that this week marks your last chance to secure the final discounted rates for you and your team. Register by this Friday to save up to $300 on your pass alongside all of the key players in the field.
We look forward to seeing you there.
Scan to learn more:
